Areas of Focus
- Omics and AI in cardiovascular disease biomarker selection
- Pharmacological research in traditional Chinese medicine for cardiovascular diseases
Work Experience
- 2020-06 to 2023-06 - China Pharmaceutical University, Postdoctoral Researcher
- 2023-07 to present - Shanghai University School of Medicine, Associate Professor
Academic Background & Achievements
- 2020 - PhD in Pharmacognosy from China Pharmaceutical University
- Published 20 articles in authoritative journals
- First author in 10 SCI articles
- Filed 3 invention patents, 1 granted
- Led 4 major projects including national and provincial funds
Publications
- Kynurenine 3-monooxygenase as a novel target for myocardial ischemia through regulating mitochondrial quality control and the therapeutic effects of ginsenoside Rb3, Qiong Lai, Lingling Wu, Shuhong Dong, et al., 2023
- Inhibition of OAT1/3 attenuates myocardial ischemia-induced chronic heart failure via decreasing fatty acid oxidation and the therapeutic effects of ruscogenin, Qiong Lai, Xiaozhou Zhu, Lu Zhang, et al., 2023